|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 49, 2419-2426, November 2008 Conformational change of apolipoprotein A-I and HDL formation from model membranes under intracellular acidic conditions
* Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan Published, JLR Papers in Press, July 21, 2008. This study was supported in part by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (17390011 and 20790032), research fellowships from the Japan Society for the Promotion of Science for Young Scientists (202796), and the program for the Promotion of Fundamental Studies in Health Science (04-8) of the National Institute of Biomedical Innovation.
1 To whom correspondence should be addressed: e-mail: mnakano{at}pharm.kyoto-u.ac.jp
The molecular mechanism by which nascent HDL forms via the interaction of apolipoprotein A-I (apoA-I) and transmembrane ABCA1 is poorly understood. Here, because ABCA1 has been reported to localize to acidic intracellular compartments, including the Golgi and endosome, we studied the interaction of apoA-I with model membranes under acidic conditions. Pure phosphatidylcholine liposomes were persistent against apoA-I at pH levels above 5.0, but were progressively transformed into reconstituted HDLs (rHDLs) by apoA-I at lower pH. Circular dichroism spectral measurements and 8-anilino-1-naphthalenesulfonic acid fluorescence measurements of lipid-free apoA-I ascribed this accelerated rHDL formation to the conformational change of the protein into a rather hydrophobic
Supplementary key words endosome Golgi phosphatidylcholine phosphatidylserine reconstituted HDL translocase activity Abbreviations: ANS, 8-anilino-1-naphthalenesulfonic acid; apoA-I, apolipoprotein A-I; CD, circular dichroism; LUV, large unilamellar vesicle; PC, phosphatidylcholine; PL, phospholipid; PS, phosphatidylserine; rHDL, reconstituted HDL; Rho-DOPE, dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||